Neurizon Therapeutics Limited ABN 35 094 006 023 www.neurizon.com Suite 2, Level 11, 385 Bourke Street, Melbourne, VIC 3000 Tel: +61 3 9692 7222 FDA Type C Meeting affirms ongoing HEALEY ALS Platform Trial as potentially registrational ? US Food and Drug Administration (FDA) provides...